Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?

Affiliations

¹ Unit of Cancer Epidemiology, Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium; Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, University Ghent, Ghent, Belgium. Electronic address: marc.arbyn@sciensano.be.
² Scottish HPV Reference Laboratory, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK.
³ Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
⁴ Molecular Pathology Laboratory, Department of Pathology, Copenhagen University Hospital, Hvidovre, Denmark.

Free article

Comment

Marc Arbyn et al. Clin Microbiol Infect. 2023 Dec.

Free article

. 2023 Dec;29(12):1608-1609.

doi: 10.1016/j.cmi.2023.08.020. Epub 2023 Aug 25.

¹ Unit of Cancer Epidemiology, Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium; Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, University Ghent, Ghent, Belgium. Electronic address: marc.arbyn@sciensano.be.
² Scottish HPV Reference Laboratory, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK.
³ Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
⁴ Molecular Pathology Laboratory, Department of Pathology, Copenhagen University Hospital, Hvidovre, Denmark.

No abstract available

Comment on

Re: '2020 list of human papillomavirus assays suitable for primary cervical cancer screening' by Arbyn et al.
Giuffrè G, Iacobellis M. Giuffrè G, et al. Clin Microbiol Infect. 2023 Dec;29(12):1606-1607. doi: 10.1016/j.cmi.2023.08.009. Epub 2023 Aug 16. Clin Microbiol Infect. 2023. PMID: 37595800 No abstract available.